Steadybase.

MDxHealth SA.

Website LinkedIn
  • MDXH · Nasdaq
  • Services-Medical Laboratories
  • Herstal, C9
  • 364 employees
  • CIK 0001872529

Updated from SEC filings through

Top things to know

Executives

MDxHealth SA is a U.S. public company in services-medical laboratories (SIC 8071), headquartered in Herstal, C9. It trades as MDXH on Nasdaq. Revenue was $108M in the fiscal year ending December 31, 2025, +19.8% from the year before. It reported about 364 employees. Michael McGarrity is Chief Executive Officer.

Five-year financials

MetricFY2025FY2024FY2023FY2022FY2021
Revenue $108M
20-F, 2026-04-03
$90.0M
20-F, 2026-04-03
$70.2M
20-F, 2026-04-03
$37.1M
20-F, 2025-03-31
$22.2M
20-F, 2024-04-30
Operating income -$14.4M
20-F, 2026-04-03
-$24.7M
20-F, 2026-04-03
-$27.3M
20-F, 2026-04-03
-$37.9M
20-F, 2025-03-31
-$26.8M
20-F, 2024-04-30
SG&A Not on file Not on file Not on file Not on file Not on file
Net income -$33.5M
20-F, 2026-04-03
-$38.1M
20-F, 2026-04-03
-$43.1M
20-F, 2026-04-03
-$44.0M
20-F, 2025-03-31
-$29.0M
20-F, 2024-04-30

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Michael McGarrity
Chief Executive Officer, Executive and Managing Director MDxHealth, Inc.
Chief Executive Officer Form 4, June 3, 2026
Ron Kalfus
Strategic Finance Leader & CPA | IPO (NASDAQ) & SEC Reporting Specialist | Private Equity, M&A, and Business Transformation
Chief Financial Officer Form 3, April 13, 2026
John Bellano
Healthcare Commercial Executive | Diagnostics & Precision Medicine | Growth, Revenue Cycle, Integration & Enterprise Execution
Chief Commercial Officer Form 4, June 3, 2026
Brendan OConnell VP, Finance and Accounting Form 4, June 3, 2026

What MDxHealth SA does

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases.com/company/mdxhealth.

Press release "About" paragraph, 10-K for the year ending October 16, 2026

Shares and governance

Shares outstanding 51.4 million (as of December 31, 2025) 20-F, April 3, 2026
Auditor BDO Réviseurs d’Entreprises SRL (Zaventem, Belgium) Latest 10-K

Insider trades

Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.

DateInsiderTradeSharesValueSource
August 13, 2026 Eric Bednarski
Director
Buy 2,202,643 $991K Form 4, August 17, 2026
August 13, 2026 Partners LLC MVM
Director
Buy 2,202,643 $991K Form 4, August 17, 2026

Recent 8-K events

No 8-K filings on file.

Frequently asked questions about MDxHealth SA

What does MDxHealth SA do?
In its own words, from Item 1 of its 10-K: "Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases.com/company/mdxhealth."
What is MDxHealth SA's revenue?
$108M for the fiscal year ending December 31, 2025, from its 20-F filed April 3, 2026.
Is MDxHealth SA profitable?
MDxHealth SA reported net income of -$33.5M for the fiscal year ending December 31, 2025.
How many employees does MDxHealth SA have?
About 364 as of December 31, 2025, as stated in its annual report.
Who is the CEO of MDxHealth SA?
Michael McGarrity, Chief Executive Officer, as named in a 4 filed June 3, 2026.
Who is the CFO of MDxHealth SA?
Ron Kalfus, Chief Financial Officer, as named in a 3 filed April 13, 2026.
Where is MDxHealth SA headquartered?
Herstal, C9.
What is MDxHealth SA's stock ticker?
MDXH on Nasdaq.
What industry is MDxHealth SA in?
Services-Medical Laboratories, SIC code 8071.
What is MDxHealth SA's website?
mdxhealth.com.
When does MDxHealth SA report earnings next?
February 11, 2027. This is an estimate from past filing dates, not a confirmed date.
Is MDxHealth SA a public company?
Yes. MDxHealth SA files with the SEC under CIK 0001872529 and trades as MDXH.
Who audits MDxHealth SA?
BDO Réviseurs d’Entreprises SRL, Zaventem, Belgium, as named in its latest annual report (10-K).
How many shares of MDxHealth SA are outstanding?
51.4 million shares as of December 31, 2025, from its 20-F filed April 3, 2026.
Have MDxHealth SA insiders traded stock recently?
Since August 13, 2026, officers and directors reported 0 open-market sales and 2 purchases worth about $2.0M on Forms 4 and 5. The most recent: Eric Bednarski (Director) bought 2,202,643 shares on August 13, 2026.